P18. Predictive role of serum tumor markers NSE and TK in patients with advanced-stage NSCLC treated with EGFR-TKIs

BACKGROUND: Targeted treatment based on tyrozine kinase inhibitors (TKI) directed at epidermal growth factor receptor (EGFR) represents a novel effective tool in management of advanced-stage non-small cell lung cancer (NSCLC). Although, activating EGFR gene mutations represent currently the stronges...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Fiala, Ondrej, Pesek, Milos, Finek, Jindrich, Benesova, Lucie, Minarik, Marek, Bortlicek, Zbynek, Topolcan, Ondrej
Formato: Artigo
Idioma:Inglês
Publicado em: Pioneer Bioscience Publishing Company 2014
Assuntos:
CELCC 2014 Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367793/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB030
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados